Note: Descriptions are shown in the official language in which they were submitted.
CA 02304420 2000-04-03
1
NOVEL PROCESS FOR SYNTHESIZING PARA-
AND/OR META-SUBSTITUTED CYANOPHENYLALANINE
DERIVATIVES
TECHNICAL FIELD
The present invention relates to a novel process for synthesizing
non-natural amino acids, para- and/or meta-substituted cyanophenylalanine
derivatives represented by the following formula ( 1 ):
A
R1HN
~O
~C~n
(1)
in which
Ri represents ammo-protecting group,
A represents -OR2 (wherein, R2 represents hydrogen, lower-alkyl,
R3
-N
cycloalkyl or phenyl) or ~ (wherein, R3 and Ra independently of one
another represent hydrogen, lower-alkyl or cycloalkyl, or together with the
nitrogen atom to which they are attached represent heterocyclic group),
n represents an integer of 1 or 2, and the -CN group is located at
para or meta position, and their isomers. More specifically, the present
invention relates to a process for preparing the compound of formula (1)
and its stereoisomer, characterized in that a compound represented by the
following formula (2):
CA 02304420 2000-04-03
2
R1HN
(2)
in which
R represents fluorosulfonyl, trifluoromethanesulfonyl or nonafluoro-
butanesulfonyl,
Rl, A and n are defined as previously described, and
the -OR group is located at para or meta position, is reacted with a
cyanide in the presence of a nickel catalyst.
BACKGROUND ART
The para- and/or meta-substituted cyanophenylalanine derivatives are
important intermediate in medicinal chemistry. Particularly, it acts as a very
useful intermediate for preparing the thrombin inhibitor LB30057 which has
been recently developed by LG Chemical Ltd. as a selective and orally-
administered thrombin inhibitor. Therefore, establishment of the effective
manufacturing process thereof is very important for preparing LB30057.
/ \ ~N~
\ I / s~~~o
ii ~~
O O
\ ~ ~NHz
NH
LB30057
CA 02304420 2000-04-03
3
Further, para- and/or meta-substituted cyanophenylalanine derivatives
have been used as a key intermediate in the preparation of the existing
thrombin inhibitor CRC 220(Terahedron, 1995, 51, 12047) and GPIIb/IIIa
receptor antagonist(J. Med. Chem. 1996, 39, 1372).
For the synthesis of para- and/or meta-substituted cyanophenylalanine
derivatives, catalytic asymmetric hydrogenation (Terahedron, 1995, 51,
12047), alkylation of the enolate of glycine derivative(J. Chem. Soc. Perkin
Trans l, 1996, 645 and J. Am. Chem. Soc. 1997, 119, 656) have been
disclosed. These methods, however, have some drawbacks therewith that
deprotection during the synthesis is not easy and large scale production can
hardly be achieved thereby.
The present inventors have already developed a process for
preparation of said intermediate based on a cyanation reaction using a
palladium catalyst as a result of extensive study. Then, we filed a patent
application claiming the invention(Korean Patent Application No. 97-41254).
Under such a technical situation, the present inventors have
constantly tried to economically and conveniently prepare the useful
medicinal intermediate, compound of formula (1) above. During the tries,
unexpectedly, we found that such a purpose can be accomplished by
reacting the compound of formula (2) with a cyanide in the presence of a
nickel catalyst, and then completed the present invention.
3o DISCLOSURE OF THE INVENTION
Therefore, it is an object of the present invention to provide a
process for preparing the compound of formula (1) with a high yield from
the phenylalanine derivative of formula (2) in the presence of an inorganic
cyanide salt and a nickel catalyst. The process for preparing the compound
CA 02304420 2000-04-03
4
of formula (1) from the compound of formula (2) is depicted in the
following reaction scheme 1.
Reaction Scheme 1
A
R1HN O
Rl~ Ni(0)
CN-
(C~n
(2) (1)
in which
R represents fluorosulfonyl, trifluoromethanesulfonyl or nonafluoro-
butanesulfonyl,
Ri represents amino-protecting group,
A represents -OR2 (wherein, R2 represents hydrogen, lower-alkyl,
R3
-N
cycloalkyl or phenyl) or ~ (wherein, R3 and R4 independently of one
another represent hydrogen, lower-alkyl or cycloalkyl, or together with the
nitrogen atom to which they are attached represent heterocyclic group),
n represents an integer of 1 or 2, and
the -CN(or -OR) group is located at para or meta position.
DETAILED DESCRIPTION OF THE INVENTION
The process summarized in the above reaction scheme 1 are more
specifically explained as follows.
Through the present specification, the starting and object compounds
CA 02304420 2000-04-03
wherein A is restricted to -OR2 are cited by adding "-A" to the , compound
number.
In the definitions for the substituents of the compound of formula
(1), the term "amino-protecting group" means the conventionally used one
in the field of organic synthesis, which includes carbonyl groups such as
fluorenylmethyloxycarbonyl, phthalyl, t-butoxycarbonyl, benzyloxycarbonyl,
etc., or aromatic- or heteroaromatic sulfonyl groups such as toluenesulfonyl,
benzenesulfonyl, naphthalenesulfonyl, benzothiazole-2-sulfonyl, 5-methyl
1,3,4-thiadiazole-2-sulfonyl, etc.; the term "lower-alkyl" means a saturated
and straight-chain or branched hydrocarbon radical having 1 to 4 carbon
atoms, which includes methyl, ethyl, isopropyl, n-butyl, isobutyl and t-butyl;
the term "cycloalkyl" means cyclic alkyl having 3 to 8 carbon atoms, which
includes cyclopentyl; and the term "heterocyclic group" means 5- or
6-membered saturated or unsaturated ring containing one or two nitrogen
atoms) which may be substituted, the representative example of which is
4-methylsulfonyl-piperazine.
The compound of formula (1) can exist as a pure stereoisomer such
as enantiomer of R or S, and therefore, without a specific mention
hereinafter, the present invention is understood to include each of these
stereoisomers and their mixtures.
The nickel catalyst used in the process according to the present
invention is produced by reducing a nickel divalent compound with a
reducing agent. The nickel divalent compound which can be used for this
purpose includes Ni(PPh3)2C12, Ni(PPh3)zBrz, NiBrz, NiCl2, Ni(acac)2,
Ni(OAc)z(wherein, Ph means phenyl, ac or Ac means acetate), etc. These
compounds are reduced with zinc, n-BuLi or DIBAL(diisobutylaluminum-
chloride) in the reaction solution in the presence of triphenylphosphine or
its
derivative to produce a Ni compound having 0 valence[Ni(0)J which actually
CA 02304420 2000-04-03
6
acts as the nickel catalyst in the process according to the present invention.
As far as the catalyst thus obtained functions in the desired manner, there
are no restriction on the kind of catalyst compound or reducing agent.
This reaction has been used for converting trifluoromethanesulfonyl group in
a simple benzene compound into cyano group(Chem. Lett. 1989, 1957),
which, however, has never been applied to the more complicated
compounds.
It is preferable to use the catalyst in an amount of 1-20mo1% with
respect to the compound of formula (2) since using the excess reagent of
more than 20mo1% is uneconomic.
The reducing agent zinc, n-BuLi or DIBAL is suitably used in an
amount of 1 equivalent with respect to the nickel divalent compound.
However, there is no influence on the reaction when the reducing agent is
used in excess. Triphenylphosphine or its derivative which acts as a ligand
is used in an amount of 1 to 5 equivalents with respect to the nickel
compound because the stabilization of Ni(0) catalyst can be achieved in said
range and the reaction can hardly be completed due to the decomposition of
the catalyst when the ligand is used in an amount of less than 1 equivalent.
Whatever cyanides generate cyanide ion into the reaction medium
can be used in the present invention. Preferably, one or more selected
from the group consisting of KCN, NaCN and Zn(CN)2 is used. In the
case of KCN and NaCN, the cyanide is preferably used in an amount of 1
to 2.5 times molar amount with respect to the compound of formula (2),
and in the case of Zn(CN)2, it is preferably used in an amount of 0.5 to
1.5 times molar amount to the compound (2). When the cyanide is used in
an amount of more than the respective upper limit, it may react with Ni(0)
catalyst to cause the reduction of catalyst activity.
CA 02304420 2000-04-03
7
The reaction is carried out at temperatures ranging from 40 to
80°C,
and one or more selected from the group consisting of acetonitrile,
tetrahydrofuran(THF), dimethylformamide(DMF), dimethylsulfoxide(DMSO)
and N-methylpyrrolidone(NMP) are used as the solvent. The compound of
formula ( 1 ) may be obtained through the reaction as explained above with a
yield of about 80-90%.
While, the compound of formula (2), the starting material in the
process of the present invention, may be prepared according to the processes
depicted in the following reaction schemes 2 and 3. That is, the compound
of formula (2) may be prepared by protecting first the amino group of the
cheap starting compound such as D- or L-tyrosine, 3,4-dihydroxyphenyl-
alanine, or ester derivative thereof and then converting the hydroxy groups)
into the corresponding fluorosulfonyloxy, trifluoromethanesulfonyloxy or
nonafluorobutanesulfonyloxy group, respectively.
Reaction Scheme 2
HZN R1HN R1HN
(2-A)
CA 02304420 2000-04-03
8
Reaction Scheme 3
R3wN~Ra
RW Rl~ R1HN
'O
(~R)n
(2-B)
Distinctive feature of the above process represented in reaction
scheme 2 is that additional introduction of a separate hydroxy-protecting
group is not required in the course of introducing carbonyl or sulfonyl
protector into the amino group of the starting compound represented by the
following formula (3-A) or its hydrochloride salt:
2 0 HZN
(3-A)
in which, R2 and n are defined as previously described.
In case the product of formula (2) is N-sulfonyl derivative, the
30 starting compound of formula (3-A) or its hydrochloride salt is reacted
with
trimethylsilylchloride to transiently protect both amino- and hydroxy groups
with trimethylsilyl group, the desired sulfonyl protector is selectively
introduced into the amino group, and then trimethylsilyl protector is
removed from the hydroxy group during the work-up process. In case the
product of formula (2) is N-carbonyl derivative, the starting compound of
CA 02304420 2000-04-03
9
formula (3-A) or its hydrochloride salt is reacted with the corresponding
anhydride or chloroformate in the presence of potassium carbonate or
sodium carbonate and PEG(polyethyleneglycol) as a phase transition catalyst
to selectively introduce the desired carbonyl protector into the amino group.
In the reaction scheme 2, after the introduction of amino-protecting
group into the compound (3-A) is completed, the desired functional group is
introduced into the hydroxy group to give the compound of formula (2-A).
For example, trifluoromethanesulfonyl group may be introduced into the
hydroxy group by dissolving the starting compound in a mixture of pyridine
and methylene chloride then by reacting with trifluoro- methanesulfonic
anhydride. According to the similar process, fluorosulfonyl or
nonafluorobutanesulfonyl group may be introduced, respectively.
In the reaction scheme 3, N-protected compound is treated with
isobutylchloroformate(i-Bu02CC1) to afford mixed anhydride with
concomitant formation of isobutylcarbonate of the phenylhydroxy group.
Thus formed anhydride was quenched with amine(HNRsR4) and the
carbonate group was cleaved by lithium hydroxide. Then, the hydroxy
group thus generated is transformed in the same manner as the reaction
scheme 2 to give the compound(2-B).
Typical examples of the compound of formula (2) which can be
prepared according to the above processes are as follows.
Methyl-(S)-2-(t-butoxycarbonylamino)-3-(4-trifluoromethanesulfonyloxy
phenyl)propionate(2a);
Methyl-(S)-2-(benzyloxycarbonylamino)-3-(4-trifluoromethanesulfonylox
yphenyl)propionate(2b);
Methyl-(S)-2-(fluorenylmethyloxycarbonylamino)-3-(4-trifluoromethanesu
lfonyloxyphenyl)propionate(2c);
CA 02304420 2000-04-03
Methyl-(S)-2-(2-naphthalenesulfonylamino)-3-(4-trifluoromethanesulfonyl
oxyphenyl)propionate(2d);
Methyl-(S)-2-(2-naphthalenesulfonylamino)-3-(4-nonafluorobutanesulfony
loxyphenyl)propionate(2e);
Methyl-(S)-2-(p-toluenesulfonylamino)-3-(4-trifluoromethanesulfonyloxyp
henyl)propionate(2f);
Methyl-(S)-2-(benzenesulfonylamino)-3-(4-trifluoromethanesulfonyloxyph
enyl)propionate(2g);
10 Methyl-(S)-2-(benzothiazole-2-sulfonylamino)-3-(4-trifluoromethanesulfo
nyloxyphenyl)propionate(2h);
Methyl-(S)-2-(2-naphthalenesulfonylamino)-3-(4-fluorosulfonyloxyphenyl
)propionate(2i);
(S)-N-cyclopentyl-N' -methyl-3-(4-trifluoromethanesulfonyloxyphenyl)-2-
(t-butoxycarbonylamino)propionamide(2j );
(S)-N-cyclopentyl-N'-methyl-3-(4-trifluoromethanesulfonyloxyphenyl)-2-[
(naphthalen-2-yl)sulfonylamino]propionamide(2k);
(S)-4-[2-(t-butoxycarbonyl-amino)-3-(4-methylsulfonyl-piperazinyl)-3-oxo
-propyl]benzenetrifluoromethanesulfonate(21);
(S)-N-(2-methylpropyl)-3-(4-trifluoromethanesulfonyloxyphenyl)-2-(t-but
oxycarbonylamino)propionamide(2m);
(S)-N-butyl-3-(4-trifluoromethanesulfonyloxyphenyl)-2-(t-butoxycarbonyl
amino)propionamide(2n);
(S)-N-cyclopentyl-3-(4-trifluoromethanesulfonyloxyphenyl)-2-(t-butoxyca
rbonylamino)propionamide(2o); and
(S)-N-cyclopentyl-N' -methyl-3-(3,4-ditrifluoromethanesulfonyloxyphenyl
)_2_(t-butoxycarbonylamino)propionamide(2p).
BEST MODE FOR CARRYING OUT THE INVENTION
The present invention will be more specifically explained in the
following preparations and examples. However, it should be understood
CA 02304420 2000-04-03
11
that they are intended to illustrate the present invention but not in any
manner to limit the scope of the present invention.
Preparation 1
Synthesis of methyl-(S)-2-(t-butozycarbonylamino)-3-(4-hydrozy
phenyl)propionate
Potassium carbonate(10.55g, 76mmol) and PEG(M.W.2000, 3g,
l.5mmo1) were suspended in 120m,~ of ethyl acetate. To this mixture was
added methyltyrosinate hydrochloride(13.8g, 59.6mmo1) and the resulting
reaction mixture was stirred for about 1.5 hours. t-Butoxycarbonyl
anhydride(Boc anhydride)(13g, 59.6mmol) was added thereto, the mixture
thus obtained was stirred at room temperature for about 20 hours and
diluted with 1N HCl solution. The organic layer was separated, and this
organic layer was washed with aqueous sodium chloride solution, dried, and
concentrated to give 16.2g(Yield 93%) of the title compound.
1H NMR(CDCIs, 300MHz) s 6.9(d, J=7.8Hz, 2H), 6.71(d, J=7.8Hz,
2H), 5.29(br.s, 1H), 4.91(br.d, 1H), 4.5(m, 1H), 3.65(s, 3H), 2.95(m, 2H)
The following compounds were prepared according to the similar
procedure as Preparation 1 above.
Methyl-(S)-2-(benzyloxycarbonylamino)-3-(4-hydroxyphenyl)propionate.
Methyl-(S)-2-(fluorenylmethyloxycarbonylamino)-3-(4-hydroxyphenyl)pr
opionate.
Preparation 2
Synthesis of methyl-(S)-2-(2-naphthalenesulfonylamino)-3-(4-
hydroxyphenyl)propionate
CA 02304420 2000-04-03
12
Methyltyrosinate(lg, 4.32mmol) was suspended in Sm~ of methylene
chloride, pyridine(1.4m,~, 17.28mmo1) was added thereto, and the reaction
mixture was allowed to stand until the mixture became thoroughly
transparent. After the reaction solution became transparent, trimethylsilyl-
chloride(l.lm.~, 8.64mmo1) was slowly added thereto at room temperature.
After 1 hour, 2-naphthalenesulfonylchloride(1.08g, 4.75mmo1) was added and
the resulting mixture was stirred for 24 hours. To this mixture was added
3N HCl solution, which was then stirred for about 2 hours. The organic
layer was separated, the aqueous layer was extracted with methylene
chloride, and the organic layers were combined. The combined organic
layer was dried over Na2S04 and the organic solvent was removed by
distillation under reduced pressure. The resulting residue was recrystallized
from toluene to give 1.29g(Yield 79%) of the title compound as a white
solid.
1H NMR(CDC13, 300MHz) s 8.33(s, 1H), 7.91(m, 3H), 7.68(m,
3H), 6.90(d, J=8.4Hz, 2H), 6.62(d, J=8.4Hz, 2H), 5.18(d, J=9.lHz, 1H),
4.92(br.s, 1H), 4.21(dt, J=15, 6.OHz, 1H), 3.37(s, 3H), 3.00(dd, J=13.5,
5.7Hz, 1H), 2.93(dd, J=14.3, 6.SHz, 1H).
The following compounds were prepared according to the similar
procedure as Preparation 2 above.
Methyl-(S)-2-(p-toluenesulfonylamino)-3-(4-hydroxyphenyl)propionate.
Methyl-(S)-2-(benzenesulfonylamino)-3-(4-hydroxyphenyl)propionate.
Methyl-(S)-2-(benzothiazole-2-sulfonylamino)-3-(4-hydroxyphenyl)propio
nate.
Preparation 3
Synthesis of methyl-(S)-2-(2-naphthalenesulfonylamino)-3-(4-
trifluoromethanesulfonyloxyphenyl)propionate(2d)
CA 02304420 2000-04-03
13
N-(2-naphthalenesulfonyl)methyltyrosinate(1.29g, 3.35mmo1) was
dissolved in pyridine(542~, 3.7mmo1) and methylene chloride(Sm.~) and the
reaction mixture was allowed to stand to a temperature of 0 °C .
Trifluoromethanesulfonyl anhydride(623~, 3.7mmo1) was slowly added
thereto. After about 3 hours, 1N HCl solution was added and the resulting
organic layer was separated. The separated organic layer was dried over
NazSOa, filtered and then the filtrate was distilled under reduced pressure.
The residue was recrystallized from 20% aqueous ethanol solution to give
1.48g(Yield 86%) of the title compound as a white solid.
1H NMR(CDCIs, 300MHz) s 8.35(s, 1H), 7.92(m, 3H), 7.68(m,
3H), 7.16(d, J=8.7Hz, 2H), 7.08(d, J=8.4Hz, 2H), 5.29(d, J=8.7Hz, 1H),
4.25(dt, J=8.7, 6.2Hz, 1H), 3.40(s, 3H), 3.12(dd, J=13.9, 5.7Hz, 1H),
3.02(dd, J=14.5, 8.1 Hz, 1 H)
The following compounds were prepared according to the similar
procedure as Preparation 3 above.
Methyl-(S)-2-(t-butoxycarbonylamino)-3-(4-trifluoromethanesulfonyloxyp
henyl)propionate(2a).
Methyl-(S)-2-(benzyloxycarbonylamino)-3-(4-trifluoromethanesulfonylox
yphenyl)propionate(2b).
Methyl-(S)-2-(fluorenylmethyloxycarbonylamino)-3-(4-trifluoromethanesu
lfonyloxyphenyl)propionate(2c).
Methyl-(S)-2-(p-toluenesulfonylamino)-3-(4-trifluoromethanesulfonyloxyp
henyl)propionate(2f).
Methyl-(S)-2-(benzenesulfonylamino)-3-(4-trifluoromethanesulfonyloxyph
enyl)propionate(2g).
Methyl-(S)-2-(benzothiazole-2-sulfonylamino)-3-(4-trifluoromethanesulfo
nyloxyphenyl)propionate(2h).
CA 02304420 2000-04-03
14
Further, the same procedure as Preparation 3 was carried out except
that nonafluorobutanesulfonylchloride was used instead of trifluoromethane-
sulfonyl anhydride to give methyl-(S)-2-(2-naphthalenesulfonylamino)-3-(4-
nonafluorobutanesulfonyloxyphenyl)propionate(2e), and the same procedure as
Preparation 3 was carried out except that fluorosulfonylchloride was used
instead of trifluoromethanesulfonyl anhydride to give methyl-(S)-2-(2-
naphthalenesulfonylamino)-3-(4-fluorosulfonyloxyphenyl)propionate(2i).
preparation 4
Synthesis of (S)-N-cyclopentyl-N' -methyl-3-(4-trifluoromethane
sulfonyloxyphenyl)-2-(t butoxycarbonylamino)propionamide(2j)
Boc(t-butoxycarbonyl)-tyrosine(70.33g, 0.25mo1) was dissolved in
tetrahydrofuran(450m.~), which was then cooled to -20 °C . N-
methylmorpholine
(101.15g, l.Omo1) was added thereto, and isobutylchlorofonmate(70.Og,
0.513mo1) was slowly added. Cyclopentylmethylamine hydrochloride(37.30g,
0.275mo1) was added to the resulting solution, which was then stirred for
about 4 hours at room temperature. Tetrahydrofuran was removed and the
residue was extracted with 1N hydrochloric acid solution(SOOm,~) and
diethylether{900m.~). The organic layer was dried over anhydrous
magnesium sulfate and distilled under reduced pressure. The residue was
dissolved in tetrahydrofuran(400m.~) and cooled to -5 C . LiOH . H20(31.47g)
and water(200m,~) were added thereto and the mixture was stirred for 2
hours. Tetrahydrofuran was removed and the residue was extracted with 1N
hydrochloric acid solution(120m.~) and ethylacetate(750m.~). The organic layer
was dried over anhydrous magnesium sulfate and distilled under reduced
pressure. The residue was dissolved in dichloromethane(470m,~) and pyridine
(59.33g, 0.75mo1), to which was slowly added at -20°C a solution
wherein
trifluoromethanesulfonic anhydride(105.80g, 0.375mo1) was dissolved in
dichloromethane(SOm.~). The reaction mixture was stirred at the same
temperature for 3 hours and extracted with 1N hydrochloric acid solution
CA 02304420 2000-04-03
(300m.~). The organic layer . was dried over anhydrous magnesium sulfate
and distilled under reduced pressure. The residue was purified by silica gel
column chromatography(hexane/ethylacetate=2/1, v/v) to give 450g(Yield
91%) of the title compound.
Preparation 5
Synthesis of (S)-N-cyclopentyl-N'-methyl-3-(4-trifluoromethane-
sulfonyloxyphenyl)-2-[(naphthalen-2-yl)sulfonylamino]propionamide(2k)
(S)-N-cyclopentyl-N' -methyl-3-(4-trifluoromethanesulfonyloxyphenyl)-2-
(t-butoxycarbonylamino)propionamide(1.81g, 3.66mmol) prepared in
Preparation 4 was dissolved in dichloromethane(20m~), which was then
cooled to 0 °C . Trifluoroacetic acid(7.Om,~) was added and the
resulting
mixture was stirred for 1 hour. Sufficient amount of saturated sodium
hydrogen carbonate solution was added thereto to make the mixture weak
basic. This mixture was extracted twice with dichloromethane, then the
separated organic layer was washed with aqueous sodium chloride solution,
dried and concentrated to obtain (S)-N-cyclopentyl-N' -methyl-3-(4-trifluoro-
methanesulfonyloxyphenyl)-2-aminopropionamide. The resulting compound
was dissolved in dichloromethane(17m.~), N-methylmorpholine(654mg,
6.47mmol) was added thereto, and the mixture was cooled to 0 °C . To
this
mixture was slowly added the solid (naphthalen-2-yl)sulfonylchloride(0.92g,
4.OSmmo1). After 2 hours, the solution was extracted twice with
dichloromethane. The organic layer was combined, washed with aqueous
sodium chloride solution, and concentrated under reduced pressure. The
concentrate was dissolved in methanol, which was then allowed to stand at
room temperature. The resulting solid was filtered to give 1.2g of the title
compound, and the filtrate was concentrated again and crystallized in the
same manner to give 0.61g of the title compound. The total yield of the
two steps was 85%.
CA 02304420 2000-04-03
16
iH-NMR(CDC13, ppm)s :8.32(d, J=8.7Hz, 1H), 7.88(m, 3H), 7.73(m,
1 H), 7.61 (m,2H), 7.21 (t, J=7.8Hz, 2H), 7.11 (t, J=7.8Hz, ZH) 5.97(dd,
J=16.3,
9.3Hz, 1H), 4.51, 4.32, 3.67(q, J=6.9Hz, m, and quintet, J=8.25, total 2H),
2.96(m, 2H), 2.32, 2.04{s, 3H), 1.45-0.35(m, 8H).
MS(FAB, m/e): 585(M++1)
The following compounds were prepared according to the similar
procedure as Preparation 4 or 5 above.
(S)-4-[2-(t-Butoxycarbonyl-amino)-3-(4-methylsulfonyl-piperazinyl)-3-ox
o-propyl]benzenetrifluoromethanesulfonate(21);
(S)-N-(2-methylpropyl)-3-(4-trifluoromethanesulfonyloxyphenyl)-2-(t-but
oxycarbonylamino)propionamide(2m);
(S)-N-butyl-3-(4-trifluoromethanesulfonyloxyphenyl)-2-(t-butoxycarbonyl
amino)propionamide(2n);
(S)-N-cyclopentyl-3-(4-trifluoromethanesulfonyloxyphenyl)-2-(t-butoxyca
rbonylamino)propionamide(2o);
(S)-N-cyclopentyl-N' -methyl-3-(3,4-ditrifluoromethanesulfonyloxyphenyl
-2-(t-butoxycarbonylamino)propionamide(2p).
Example 1
Synthesis of methyl-(S)-2-(2-naphthalenesulfonylamino)-3-(4-cyano
phenyl)propionate
Ni(PPh3)2C12(15mo1%, 95mg, 0.145mmol), PPh3(76mg, 0.29mmol),
KCN (118mg, 1.81mmo1), Zn(32mg, 0.49mmo1) and methyl-(S)-2-(2-
naphthalenesulfonylamino)-3-(4-trifluoromethanesulfonyloxyphenyl)propionate
(2d)(O.Sg, 0.97mmo1) were dissolved in 2m.~ of NMP and the reaction
mixture was heated at SS °C under nitrogen atmosphere for about 2.5
hours.
The mixture was cooled to room temperature and 3N HCl solution was
added thereto. The mixture was stirred for about 1 hour and the filtrate
CA 02304420 2000-04-03
17
was distilled under reduced pressure. The residue was separated and
purified by column chromatography(silica gel, hexane/ethylacetate=5:1 to 1:1)
to give 312mg(Yield 89%) of the title compound as a white solid.
1H NMR(CDCIs, 300MHz) s 8.31(s, 1H), 7.89(m, 3H), 7.67(m,
3H), 7.39(d, J=6.SHz, 2H), 7.17(d, J=6.SHz, 2H), 5.57(d, J=8.9Hz, 1H),
4.27(m, 1H), 3.45(s, 3H), 3.15(dd, J=13.8, 4.3Hz, 1H), 3.00(dd, J=13.4,
6.1 Hz, 1 H)
Example 2
Synthesis of methyl-(S)-2-(2-naphthalenesulfonylamino)-3-(4-cyano
phenyl)propionate
The title compound was given with a yield of 90% according to the
same procedure as Example 1 except that methyl-(S)-2-(2-naphthalenesulfonyl
amino)-3-(4-nonafluorobutanesulfonyloxyphenyl)propionate(2e) was used as the
starting material instead of methyl-(S)-2-(2-naphthalenesulfonylamino)-3-(4-
trifluoromethanesulfonyloxyphenyl)propionate(2d).
Example 3
Synthesis of methyl-(S)-2-(t-butoxycarbonylamino)-3-(4-cyanophenyl
)propionate
The title compound was given with a yield of 90% according to the
same procedure as Example 1 except that methyl-(S)-2-(t-butoxycarbonyl
amino)-3-(4-trifluoromethanesulfonyloxyphenyl)propionate(2a) was used as the
starting material instead of methyl-(S)-2-(2-naphthalenesulfonylamino)-3-(4-
trifluoromethanesulfonyloxyphenyl)propionate(2d).
1H NMR(CDCl3, SOOMHz) s 7.57(d, J=7.8Hz, 2H), 7.24(d, J=7.8Hz,
2H), 5.03(d, J=6.9Hz, 1H), 4.59(d, J=6.9Hz, 1H), 3.73(s, 3H), 3.20-3.05(m,
CA 02304420 2000-04-03
18
2H), 1.39(s, 9H)
Example 4
Synthesis of methyl-(S)-2-(benzyloxycarbonylamino)-3-(4-cyano
phenyl)propionate
The title compound was given with a yield of 88% according to the
same procedure as Example 1 except that methyl-(S)-2-(benzyloxy
c~bonylamino)-3-(4-trifluoromethanesulfonyloxyphenyl)propionate(2b) was
used as the starting material instead of methyl-(S)-2-(2-naphthalenesulfonyl-
amino)-3-(4-trifluoromethanesulfonyloxyphenyl)propionate(2d).
1H NMR(CDC13, SOOMHz) s 7.7-7.2(m, 9H), 5.1(s, 2H), 4.95(d,
J=6.9Hz, 1H), 4.59(d, J=6.9Hz, 1H), 3.78(s, 3H), 3.20-3.05(m, 2H)
Example 5
Synthesis of methyl-(S)-2-(fluorenylmethyloxycarbonylamino)-3-(4-
cyanophenyl)propionate
The title compound was given with a yield of 92% according to the
same procedure as Example 1 except that methyl-(S)-2-(fluorenylmethyloxy-
carbonylamino)-3-(4-trifluoromethanesulfonyloxyphenyl)propionate(2c) was
used as the starting material instead of methyl-(S)-2-(2-naphthalenesulfonyl-
amino)-3-(4-trifluoromethanesulfonyloxyphenyl)propionate(2d).
1H NMR(CDCIs, SOOMHz) s 7.9-7.1 (m, 17H), 4.95(d, J=6.9Hz,
1H), 4.59(m, 3H), 4.20(t, 1H), 3.78(s, 3H), 3.28-3.1(m, 2H)
Example 6
Synthesis of methyl-(S)-2-(p-toluenesulfonylamino)-3-(4-cyanophenyl
)propionate
CA 02304420 2000-04-03
19
The title compound was given with a yield of 87% according to the
same procedure as Example 1 except that methyl-(S)-2-(p-toluenesulfonyl-
amino)-3-(4-trifluoromethanesulfonyloxyphenyl)propionate(2f) was used as the
starting material instead of methyl-(S)-2-(2-naphthalenesulfonylamino)-3-(4-
trifluoromethanesulfonyloxyphenyl)propionate(2d).
1H NMR(CDCl3, 300MHz) s 7.8(d, J=7.5Hz, 2H), 7.4(d, J=7.5Hz,
2H), 7.30(d, J=6.5Hz, 2H), 7.05(d, J=6.5Hz, 2H), 5.30(d, J=9.lHz, 1H),
4.27(m, 1H), 3.45(s, 3H), 3.10(dd, J=13.8, 4.3Hz, 1H), 3.05(dd, J=13.4,
6.lHz, 1H), 2.7(s, 3H)
Example 7
Synthesis of methyl-(S)-2-(benzenesulfonylamino)-3-(4-cyanophenyl)
propionate
The title compound was given with a yield of 89% according to the
see procedure as Example 1 except that methyl-(S)-2-(benzenesulfonyl-
amino)-3-(4-trifluoromethanesulfonyloxyphenyl)propionate(2g) was used as the
starting material instead of methyl-(S)-2-(2-naphthalenesulfonylamino)-3-(4-
trifluoromethanesulfonyloxyphenyl)propionate(2d).
1H NMR(CDC13, 300MHz) s 7.8-7.30(m, 7H), 7.05(d, J=6.5Hz,
2H), 5.26(d, J=9.lHz, 1H), 4.19(m, 1H), 3.38(s, 3H), 3.19(dd, J=13.8,
4. 3 Hz, 1 H), 3 .10(dd, J=13 .4, 6.1 Hz, 1 H)
Example 8
Synthesis of (S)-N-cyclopentyl-N'-methyl-3-(4-cyanophenyl)-2-(t-
butogycarbonylamino)propionamide
To a mixture of (S)-N-cyclopentyl-N' -methyl-3-(4-trifluoromethane-
sulfonyloxyphenyl)-2-(t-butoxycarbonylamino)propionamide(2j)(lg, 2.02mmol)
CA 02304420 2000-04-03
prepared in Preparation 4, triphenylphosphine(106mg, 0.404mmo1), potassium
cyanide(197mg, 3.03mmol), zinc(132mg, 2.02mmo1) and Ni(PPh3)2C12(65.4mg,
O.lOmmol) was added N-methylpyrrolidone(NMP)(2m.~) at room temperature
under nitrogen atmosphere, and the whole mixture was stirred. After
stirring for about 5 minutes, the initial green color of the reaction mixture
was changed to dark red-brown. This mixture was heated at 75 °C for
about 3 hours and then cooled to room temperature. To the mixture was
added 3N hydrochloric acid solution(lOm,~), the resulting mixture was stirred
10 for about 30 minutes and then ethylacetate(15m.~) was added thereto. After
the organic layer was separated from the mixture, the separated organic
layer was washed with saturated aqueous sodium chloride solution(lOm.~),
dried over anhydrous sodium sulfate, and then filtered. The filtrate was
concentrated under reduced pressure and the residue was purified by silica
gel column chromatography(hexane/ethylacetate=7/3, v/v) to give 632mg(1.72
mmol, Yield 85%) of the title compound.
20 1H NMR(CDC13, ppm) s 7.61(m, 2H), 7.32(m, 2H), 5.48, 5.01,
4.86, 4.12(3m, 3H), 3.02(m, 2H), 2.75, 2.62(2s, 3H), 1.90-1.20(m, 17H)
MS(FAB, m/e): 371 (M++1)
Example 9
Synthesis of (S)-4-[2-(t-butoxycarbonyl-amino)-3-(4-methylsulfonyl-
piperazinyl)-3-oxo-propyl]benzonitrile
The title compound was given with a yield of 90% according to the
see procedure as Example 8 except that (S)-4-[2-(t-butoxycarbonyl-amino)-
3-(4-methylsulfonyl-piperazinyl)-3-oxo-propyl]benzenetrifluoromethanesulfonate
(21) was used as the starting material instead of (S)-N-cyclopentyl-N' -methyl
-3-(4-trifluoromethanesulfonyloxyphenyl)-2-(t-butoxycarbonylamino)propionami-
de(2j).
CA 02304420 2000-04-03
21
1H NMR(CDC13, ppm) s 7.70-7.30(m, 4H), 5.30(m, 1H), 4.81(m,
1 H), 3.90- 2.81 (m, 8H), 2.71 (s, 3H), 1.50(s, 9H)
MS(FAB, m/e): 437(M++1)
Example 10
Synthesis of (S)-N-(2-methylpropyl)-3-(4-cyanophenyl)-2-(t-butoxy-
carbonylamino)propionamide
The title compound was given with a yield of 89% according to the
same procedure as Example 8 except that (S)-N-(2-methylpropyl)-3-(4-
trifluoromethanesulfonyloxyphenyl)-2-(t-butoxycarbonylamino)propionamide(2m)
was used as the starting material instead of (S)-N-cyclopentyl-N' -methyl-3-
(4-trifluoromethanesulfonyloxyphenyl)-2-(t-butoxycarbonylamino)propionamide
(2J)~
1H NMR(CDC13, ppm) s 7.60(m, 2H), 7.33(m, 2H), 6.03(m, 1H),
5.07(m, 1H), 4.30(m, 1H), 3.20-3.00(m, 4H), 1.68(m, 1H), 1.50(s, 9H),
0.82(s, 6H)
MS(FAB, m/e): 318(M++1)
Example 11
Synthesis of (S)-N-butyl-3-(4-cyanophenyl)-2-(t butoxycarbonyl-
amino)propionamide
The title compound was given with a yield of 88% according to the
see procedure as Example 8 except that (S)-N-butyl-3-(4-trifluoromethane-
sulfonyloxyphenyl)-2-(t-butoxycarbonylamino)propionamide(2n) was used as
the starting material instead of (S)-N-cyclopentyl-N' -methyl-3-(4-trifluoro-
methanesulfonyloxyphenyl)-2-(t-butoxycarbonylamino)propionamide(2j).
1H NMR(CDC13, ppm) s 7.63(m, 2H), 7.49(m, 2H), 6.03(m, 1H),
CA 02304420 2000-04-03
22
5.18(m, 1H), 4.38(m, 1H), 3.28-3.13(m, 4H), 1.51(s, 9I-~, 1.52-1.28(m, 4H),
0.98(m, 3H)
MS(FAB, m/e): 318(M++1)
Example 12
Synthesis of (S)-N-cyclopentyl-3-(4-cyanophenyl)-2-(t-butoxy-
carbonylamino)propionamide
The title compound was given with a yield of 90% according to the
same procedure as Example 8 except that (S)-N-cyclopentyl-3-(4-trifluoro-
methanesulfonyloxyphenyl)-2-(t-butoxycarbonylamino)propionamide(2o) was
used as the starting material instead of (S)-N-cyclopentyl-N' -methyl-
3-(4-trifluoromethanesulfonyloxyphenyl)-2-(t-butoxycarbonylamino)propionamide
(2J)~
1H-NMR(CDC13, ppm) s 7.60(m, 2H), 7.32(m, 2H), 5.79(m, lI~,
5.08(m, 1 H), 4.24(m, 1 H), 4.12(m, 1 H), 3 .12(m, 2H), 1.90-1.21 (m, 8H),
1. 51 (s, 9IT)
MS(FAB, m/e): 330(M++1)
Example 13
Synthesis of (S)-N-cyclopentyl-N' -methyl-3-(3,4-dicyanophenyl)-2-(t-
butoxycarbonylam ino)propionamide
The title compound was given with a yield of 89% according to the
same procedure as Example 8 except that (S)-N-cyclopentyl-N' -methyl-3-
(3,4-ditrifluoromethanesulfonyloxyphenyl)-2-(t-butoxycarbonylamino)propionami
de(2p) was used as the starting material instead of (S)-N-cyclopentyl-N' -
methyl-3-(4-trifluoromethanesulfonyloxyphenyl)-2-(t-butoxycarbonylamino)prop-
ionamide(2j).
CA 02304420 2000-04-03
23
1H-NMR(DMSO-d6, ppm) s 8.10(m, 2H), 7.85(m, 1 H), 4.90,
4.55-4.79, 4.28 (3m, 3H), 1.80-1.10(m, 17H)
MS(FAB, m/e): 397(M++1)
Example 14
Synthesis of (S)-N-cyclopentyl-N'-methyl-3-(4-cyanophenyl)-2-
[(naphthalen-2-yl)sulfonylamino]propionamide
The title compound was given with a yield of 90% according to the
same procedure as Example 8 except that (S)-N-cyclopentyl-N'-methyl-3-(4-
trifluoromethanesulfonyloxyphenyl)-2-[(naphthalen-2-yl)sulfonylamino]propion-
amide(2k) was used as the starting material instead of (S)-N-cyclopentyl-N' -
methyl-3-(4-trifluoromethanesulfonyloxyphenyl)-2-(t-butoxycarbonylamino)prop-
ionamide(2j ).
'H-NMR(CDC13, ppm) s 8.28(d, J=10.1 Hz, 1 H), 7.88(d, J=8.7Hz,
3H), 7.69(m, 1H), 7.62(m, 2H), 7.48(dd, J=7.48, 2.8Hz, 2H), 7.23(m,
2H), 5.96(dd, J=17.5, 9.2Hz, 1 H), 4.52, 4.34, and 3.78(m, m, quintet, ZH),
2.95(m, 2H), 2.35, 2.22(s, 3H), 1.58-0.38(m, 8H)
MS(FAB, m/e): 462(M++1)
According to the process of the present invention, the useful
medicinal intermediate of para- and/or meta-substituted cyanophenylalanine
derivative can be obtained with a high yield by reacting the cheap starting
material with cyanide in the presence of a nickel catalyst.
